Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.8950
+0.0350 (1.88%)
NASDAQ · Last Trade: Apr 30th, 3:12 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors